Cargando…

Emergency of Primary NNRTI Resistance Mutations without Antiretroviral Selective Pressure in a HAART-Treated Child

OBJECTIVE: The use of antiretrovirals (ARV) during pregnancy has drastically reduced the rate of the human immunodeficiency virus perinatal transmission (MTCT). As a consequence of widespread ARV use, transmission of drug resistant strains from mothers to their babies is increasing. Ultra-sensitive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Machado, Elizabeth S., Afonso, Adriana O., Nissley, Dwight V., Lemey, Philippe, Cunha, Silvia M., Oliveira, Ricardo H., Soares, Marcelo A.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2652103/ https://www.ncbi.nlm.nih.gov/pubmed/19277127 http://dx.doi.org/10.1371/journal.pone.0004806

Ejemplares similares

Cost-Effectiveness of Early Treatment with First-Line NNRTI-Based HAART Regimens in the UK, 1996-2006
por: Beck, Eduard J., et al.
Publicado: (2011)

Tolerability of antiretroviral therapy (HAART) in elderly age
por: Celesia, B M
Publicado: (2010)

Hepatotoxicity in patients co-infected with HIV and tuberculosis while receiving NNRTI-based antiretroviral regimen and rifampicin
por: Mankhatitham, W, et al.
Publicado: (2010)

Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens
por: Manosuthi, Weerawat, et al.
Publicado: (2010)

Low-Frequency NNRTI-Resistant HIV-1 Variants and Relationship to Mutational Load in Antiretroviral-Naïve Subjects
por: Gupta, Shaili, et al.
Publicado: (2014)

Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children
por: Bunupuradah, Torsak, et al.
Publicado: (2011)

NNRTI and Liver Damage: Evidence of Their Association and the Mechanisms Involved
por: Benedicto, Ana M., et al.
Publicado: (2021)

Ophthalmic manifestations of human immunodeficiency virus infection: Pre- highly active antiretroviral chemotherapy (HAART) and post- HAART era
por: Sinha, Rajesh, et al.
Publicado: (2008)

Expression of APOBEC3G/3F and G-to-A Hypermutation Levels in HIV-1-Infected Children with Different Profiles of Disease Progression
por: Amoêdo, Nívea D., et al.
Publicado: (2011)

Increasing trends in primary NNRTI resistance among newly HIV-1-diagnosed individuals in Buenos Aires, Argentina
por: Rodriguez-Rodrigues, Nahuel, et al.
Publicado: (2013)

Pre-treatment HIV-drug resistance associated with virologic outcome of first-line NNRTI-antiretroviral therapy: A cohort study in Kenya
por: Beck, Ingrid A., et al.
Publicado: (2020)

Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women
por: Ngemu, Erastus K, et al.
Publicado: (2014)

Adiponectin and the steatosis marker Chi3L1 decrease following switch to raltegravir compared to continued PI/NNRTI-based antiretroviral therapy
por: Offor, Obiageli, et al.
Publicado: (2018)

Long‐term outcomes of rapid antiretroviral NNRTI‐based initiation among Thai youth living with HIV: a national registry database study
por: Teeraananchai, Sirinya, et al.
Publicado: (2023)

Prevalence of Hypertension in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) Compared with HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon
por: Dimala, Christian Akem, et al.
Publicado: (2016)

Multiple dosage forms of the NNRTI microbicide dapivirine: product development and evaluation
por: Romano, Joseph
Publicado: (2006)

Rilpivirine versus etravirine validity in NNRTI-based treatment failure in Thailand
por: Teeranaipong, Phairote, et al.
Publicado: (2014)

Tissue viral dynamics in SIV infected macaques with highly active antiretroviral therapy (HAART)
por: Bourry, Olivier, et al.
Publicado: (2009)

Modification of Initial Highly Active Antiretroviral Therapy (HAART) Regimen in Paediatric HIV Patients
por: Low, Yee Shan, et al.
Publicado: (2018)

The Potential of Spirulina platensis to Ameliorate the Adverse Effects of Highly Active Antiretroviral Therapy (HAART)
por: Sibiya, Thabani, et al.
Publicado: (2022)

Retraction Note: effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women
por: Ngemu, Erastus K, et al.
Publicado: (2014)

A Comparison of the Diabetes Risk Score in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) and HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon
por: Dimala, Christian Akem, et al.
Publicado: (2016)

Nephrotoxicity of HAART
por: Kalyesubula, Robert, et al.
Publicado: (2011)

Immuno-virological response and clinical outcome in naive elderly patients treated with antiretroviral therapy (HAART)
por: Bisicchia, F, et al.
Publicado: (2010)

Hypertension among HIV-Infected Adults Receiving Highly Active Antiretroviral Therapy (HAART) in Malaysia
por: Hejazi, Nazisa, et al.
Publicado: (2014)

Prevalence of Depressive Symptoms Amongst Highly Active Antiretroviral Therapy (HAART) Patients in AIDSRelief Uganda
por: Shumba, Constance, et al.
Publicado: (2013)

Clinical Implications of Mutations at Reverse Transcriptase Codon 135 on Response to NNRTI-Based Therapy
por: Tossonian, Harout K, et al.
Publicado: (2007)

High Prevalence of NRTI and NNRTI Drug Resistance Among ART-Experienced, Hospitalized Inpatients
por: Bossard, Claire, et al.
Publicado: (2021)

Pre-HAART CD4+ T-lymphocytes as biomarkers of post-HAART immune recovery in HIV-infected children with or without TB co-infection
por: Gopalakrishnan, Vivek, et al.
Publicado: (2020)

Interventions to promote adherence to Antiretroviral Therapy (HAART) among adult patients at an HIV/AIDS program in Uganda
por: Muhumuza, Simon, et al.
Publicado: (2010)

Gender-related mortality for HIV-infected patients on highly active antiretroviral therapy (HAART) in rural Uganda
por: Alibhai, Arif, et al.
Publicado: (2010)

The impact of Highly Active Antiretroviral Therapy (HAART) on the clinical features of HIV - related oral lesions in Nigeria
por: Taiwo, Olaniyi O, et al.
Publicado: (2010)

Neurobehavioral Effects in HIV-Positive Individuals Receiving Highly Active Antiretroviral Therapy (HAART) in Gaborone, Botswana
por: Lawler, Kathy, et al.
Publicado: (2011)

Chest X-ray findings in HIV- infected Highly Active Antiretroviral Treatment (HAART)-naïve patients
por: Akinbami, Akinsegun, et al.
Publicado: (2012)

Craniofacial morphology of HIV-infected adolescents undergoing highly active antiretroviral therapy (HAART): An original research
por: Neeraja, M., et al.
Publicado: (2020)

Identification of the Critical Sites of NNRTI-Resistance in Reverse Transcriptase of HIV-1 CRF_BC Strains
por: Huang, Yang, et al.
Publicado: (2014)

Efficacy of Once Daily Darunavir/Ritonavir in PI-Naïve, NNRTI-Experienced Patients in the ODIN Trial
por: Geretti, Anna Maria, et al.
Publicado: (2015)

2507. Transmitted and Acquired NNRTI Resistance in the Philippines: Are Newer Generation NNRTIs a Viable Option?
por: Theresa Dungca, Nina, et al.
Publicado: (2019)

High-resolution view of HIV-1 reverse transcriptase initiation complexes and inhibition by NNRTI drugs
por: Ha, Betty, et al.
Publicado: (2021)

Neurodegeneration in the HAART era
por: Brew, Bruce J
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_8r9ji21rq9tke2ooq0rnvom018